SCHEMBL29319320

SCHEMBL29319320

CC(C)(C)OC(O)N1Cc2ccc(Br)cc2C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABHD6 Q9BV23 3/20 0.44
DPP8 Q6V1X1 1/20 0.39
DPP9 Q86TI2 1/20 0.39
DPP7 Q9UHL4 1/20 0.39
CARM1 Q86X55 2/20 0.39
HSD17B3 P37058 4/20 0.36
PRMT5 O14744 5/20 0.35
GABRA1 P14867 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
GABRA5 P31644 1/20 0.32
GABRA3 P34903 1/20 0.32
GABRA2 P47869 1/20 0.32
GABRB2 P47870 1/20 0.32
GABRA6 Q16445 1/20 0.32
NAMPT P43490 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
BRD4 O60885 1/20 0.32
HSP90AA1 P07900 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29319354 0.75
SCHEMBL29346821 0.74 ABHD6 (0.34) ABHD6DPP8DPP9DPP7CARM1
SCHEMBL1686844 0.73 DPP8 (0.47) ABHD6DPP8DPP9DPP7CARM1
SCHEMBL19339176 0.72 NR1H2 (0.38) DPP8DPP9DPP7PRMT5
Hydrochloric Acid SCHEMBL1687068 0.72 DPP8 (0.46) ABHD6DPP8DPP9DPP7CARM1
SCHEMBL19706104 0.71 ESR2 (0.37) GABRA1GABRG2GABRB3HSP90AA1
SCHEMBL20237351 0.70 DPP8 (0.44) ABHD6DPP8DPP9DPP7CARM1
SCHEMBL16126534 0.70 DPP8 (0.44) ABHD6DPP8DPP9DPP7CARM1
SCHEMBL16126529 0.70 DPP8 (0.44) ABHD6DPP8DPP9DPP7CARM1
SCHEMBL330056 0.70 ABHD6 (0.60) ABHD6DPP8DPP9DPP7HSD17B3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240238425-A1 HSD17B13 Inhibitors and/or Degraders PFIZER INC. (US) 2024-07-18 US disclosed
US-20240238425-A1 HSD17B13 Inhibitors and/or Degraders PFIZER INC. (US) 2024-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240238425-A1 HSD17B13 Inhibitors and/or Degraders HSD17B13, HSD17B3, HSD17B1 ABHD6 436/4885DPP8 254/4885DPP9 452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.